Cargando…
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis
Approximately 20% of pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients are currently incurable due to primary or secondary resistance to glucocorticoid-based therapies. Here we employed an integrated approach to selectively kill T-ALL cells by increasing mitochondrial reactive oxygen sp...
Autores principales: | Silic-Benussi, Micol, Scattolin, Gloria, Cavallari, Ilaria, Minuzzo, Sonia, del Bianco, Paola, Francescato, Samuela, Basso, Giuseppe, Indraccolo, Stefano, D’Agostino, Donna M., Ciminale, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070521/ https://www.ncbi.nlm.nih.gov/pubmed/30069011 http://dx.doi.org/10.1038/s41419-018-0870-9 |
Ejemplares similares
-
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
por: Silic-Benussi, Micol, et al.
Publicado: (2023) -
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
por: Silic-Benussi, Micol, et al.
Publicado: (2022) -
Mitochondrial Proteins Coded by Human Tumor Viruses
por: Cavallari, Ilaria, et al.
Publicado: (2018) -
MiR-150 in HTLV-1 infection and T-cell transformation
por: D’Agostino, Donna M., et al.
Publicado: (2022) -
Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1
por: Sharma, Varun K., et al.
Publicado: (2018)